Skip to main content

Cenix Inks Research Deal with Sygnis

Premium

Cenix BioScience announced this week that it has signed a research agreement with Sygnis Bioscience.

Under the deal, Cenix will develop and optimize multi-parametric microscopy-based assays and conduct target validation studies to identify novel therapeutic drug targets for Sygnis.

Additional terms of the arrangement were not disclosed.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.